Navigation Links
CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis
Date:10/26/2009

CFA) as compared to the placebo group. CFA is calculated based on measures of fat ingestion and fat excretion; assessing the CFA of a patient is another way to measure the absorption of fat as a percentage of fat intake in patients being tested for EPI. The primary efficacy endpoint was the change in CFA from baseline to the end of the double-blind treatment period. The CFA improved by 32.1% in the CREON® group compared to 8.8% in the placebo group, representing a statistically significant difference between CREON® and placebo (P<0.0001).

"These data add to the growing body of evidence supporting the efficacy and safety profile of CREON® across multiple conditions while also providing clarity around the appropriate dosing of pancreatic enzyme replacement therapy in these patients," said Elizabeth M. Mutisya, M.D., Vice President of U.S. Medical Affairs and Chief Medical Officer at Solvay Pharmaceuticals, Inc. "These CREON® study results are encouraging as dosing of pancreatic enzymes for patients with EPI due to CP or pancreatic surgery has not previously been well defined."

Study Details

The double-blind, randomized, placebo-controlled, two-arm, parallel-group study conducted in the United States, Eastern and Central Europe, examined the efficacy and safety of CREON® 12,000-lipase unit capsules in 52 adults aged 18 years or older with EPI due to CP or pancreatic surgery. Patients were randomized to receive CREON® 12,000-lipase unit capsules at a dose of 72,000 lipase units per main meal and 36,000 lipase units per snack or matching placebo. EPI was confirmed in all subjects through direct pancreatic function testing such as, secretin tests or fecal elastase (< 100 micrograms/g), 72-hour fecal fat determination (> 15 g/day) or pancreatectomy more than 180 days prior to study enrollment.

Upon analysis of the primary efficacy results, the mean CFA increased by 32.1% in t
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis
2. CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis
3. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
4. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
5. GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the Treatment of Relapsed Small Cell Lung Cancer
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
8. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
9. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
10. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
11. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... ORLANDO, Fla. , Aug. 27, 2014 By ... Challenge, you,re likely not living on this planet. The awareness ... social consciousness and has helped to raise over $88.5 Million ... are getting involved and some companies are starting to as ... in Orlando, Florida , who actually works ...
(Date:8/27/2014)... 2014 Pulse Systems, Inc. , an industry-leading ... Management , and Revenue Cycle Management (RCM) solutions , ... by some RCM vendors, at UBM Medica,s Practice Rx ... September 19-20, 2014.  A presenter at the ... with a new session encouraging practices to "Look before You ...
(Date:8/27/2014)... 27, 2014 An experimental drug designed to help ... first treatment for anemia of inflammation, according to results from ... online today in Blood , the Journal ... Anemia is a condition that occurs when red ... properly. When an individual has anemia, the body does not ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... Ten percent of cancer patients failed to fill their initial prescriptions ... today in the Journal of Oncology Practice ( JOP ... ). The study was based on an analysis conducted by Avalere ... 2007 to 2009. This study has also been accepted for presentation ...
... The Consumer Healthcare Products Association (CHPA), representing makers ... applauds the U.S. Food and Drug Administration (FDA) ... children the right amount of medicine. Today, the ... Committee recommended enhancing the labels of all OTC ...
Cached Medicine Technology:New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 2New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 3New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 4OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3
(Date:8/27/2014)... 2014 Many patients believe mental illness ... depression has a mortality rate of about 15%. ... slightly less, though it's offset by an alarming homicide ... order to properly treat and manage symptoms of mental ... be taken as directed. Missed dosages or cutting ...
(Date:8/27/2014)... 27, 2014 Do brands know what consumers ... to shed some light on the topic Sept. 16 when ... the Brand Activation Association and the Association ... hundreds of consumers to learn what types of marketing messages ... influencing a potential buying decision. While the survey focuses on ...
(Date:8/27/2014)... Aspirus Wausau Hospital today announced the first ... Digital O.R. at Aspirus Wausau Hospital, in Wausau, WI. ... rooms will be Buzz, a centralized surgical hub for ... planning, navigation, imaging and communications connectivity. , Buzz ... and hardware all controlled from the full HD 42” ...
(Date:8/27/2014)... Wellesley, Mass., (PRWEB) August 27, 2014 ... report, ADVANCED ORTHOPEDIC TECHNOLOGIES, IMPLANTS AND REGENERATIVE PRODUCTS ... anticipated to increase from $36.4 billion by 2014-end to ... rate (CAGR) of 3% from 2014 to 2019. New ... the major driving forces within the market. , While ...
(Date:8/27/2014)... of the leading purveyors of real and synthetic hair wigs, hair ... its products, for the coming Labor Day. , People searching for ... hair products in two ways: when they spend more than $89 ... LABOR10; while when they spend more than $299, they can save ... code is needed when securely checkout, there are about 50 products ...
Breaking Medicine News(10 mins):Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:CRN Set To Release Poll Results On What Marketing Tactics Prompt Consumers To Buy 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2
... Blue Cross Blue Shield of Michigan announced today that Kevin ... current vice president for products and marketing, will succeed Jeanne ... when Carlson retires at the end of February 2010. , ... and CEO of BCBSM, parent company of Blue Care Network. ...
... - Proposed 30-Year Lease Agreement Will Help Stevens Hospital Expand, ... Wash., Dec. 17 The Board of Commissioners for Public ... for Swedish to lease and assume management of Stevens Hospital ... agreements. The public is invited to a hearing in mid-January ...
... from physician, study finds , THURSDAY, Dec. 17 (HealthDay News) ... parents to place infants on their backs to go to ... SIDS, researchers have found. , Since the U.S. government launched ... infants placed on their backs at sleep time has increased ...
... checkout counters of clothing stores, gas stations -- and adding ... News) -- If you,re hungry while shopping for a new ... sell sweet or salty snacks, a new report finds. , ... far beyond grocery stores to hit most segments of the ...
... ... Fisher Theatre on Dec. 17 for the Detroit-area,premiere of the award-winning musical “Jersey Boys,” Beaumont ... , ... When the cast takes the stage at the Fisher Theatre on Dec. 17 for the ...
... might be more likely to try alcohol, illegal drugs ... believe that smoking cigarettes is riskier than using illicit ... , That perception may increase the likelihood that they,ll ... said. , "We are on the right track with ...
Cached Medicine News:Health News:Stevens Hospital to Affiliate with Swedish 2Health News:Stevens Hospital to Affiliate with Swedish 3Health News:Stevens Hospital to Affiliate with Swedish 4Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 3Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2
Inquire...
Inquire...
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo...
Inquire...
Medicine Products: